Director, Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART)
PI of E-C Coupling & Cardiac Arrhythmia lab
William Stokes Professor of Medicine and Pharmacology
Oates Institute for Experimental Therapeutics
Vanderbilt University School of Medicine
Division of Clinical Pharmacology
Bjorn Knollmann is the Principal Investigator of the E-C coupling and Arrhythmia Lab. He came to Vanderbilt in 2005 from Georgetown University. He is board-certified in Internal Medicine and Clinical Pharmacology. After completing residency training in Internal Medicine, a fellowship in Clinical pharmacology and graduate training in Pharmacology, he joined the Clinical Pharmacology Faculty in 2000. His primary interest is finding new mechanisms and treatments for heart rhythm disorders. His laboratory and clinical research programs are supported by National Institute of Health (NIH) R01 and American Heart Association (AHA) grants. Work in his laboratory investigates molecular arrhythmia mechanisms involving alterations in the functioning of myofilaments and calcium release channels. In addition, the lab is developing and testing new anti-arrhythmic therapies in animal models and in humans.
Bjorn Knollmann is also the associate editor of the classic textbook of pharmacology: Goodman & Gilman's The Pharmacological Basis of Therapeutics. He has served on the scientific programming committees for the American Society of Clinical Pharmacology and Therapeutics (ASCPT) and the AHA, and routinely reviews grant applications for NIH and AHA.